Skip to main content
Knight Therapeutics Inc. (KHTRF)
OTCMKTS · Delayed Price · Currency is USD
4.460
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT

Knight Therapeutics Revenue

Knight Therapeutics had revenue of 88.08M CAD in the quarter ending March 31, 2025, with 1.70% growth. This brings the company's revenue in the last twelve months to 372.78M, up 12.21% year-over-year. In the year 2024, Knight Therapeutics had annual revenue of 371.30M with 13.13% growth.

Revenue (ttm)
372.78M CAD
Revenue Growth
+12.21%
P/S Ratio
1.57
Revenue / Employee
500.37K CAD
Employees
745
Market Cap
407.35M USD

Revenue Chart

* This company reports financials in CAD.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024371.30M43.11M13.13%
Dec 31, 2023328.20M34.64M11.80%
Dec 31, 2022293.56M50.09M20.57%
Dec 31, 2021243.48M43.96M22.03%
Dec 31, 2020199.52M152.06M320.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo Inc. 1.76B
Veradigm 588.02M
Tian'an Technology Group 1.78M
Glass House Brands 200.90M
Elite Pharmaceuticals 70.00M
Northwest Biotherapeutics 1.38M
BioStem Technologies 301.83M
American Oncology Network 1.76B
Revenue Rankings

Knight Therapeutics News

More News